Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Feb 15;354(Pt 1):199–207. doi: 10.1042/0264-6021:3540199

Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion.

C Kiani 1, V Lee 1, L Cao 1, L Chen 1, Y Wu 1, Y Zhang 1, M E Adams 1, B B Yang 1
PMCID: PMC1221644  PMID: 11171095

Abstract

Aggrecan is a member of the chondroitin sulphate (CS) proteoglycan family, which also includes versican/PG-M, neurocan and brevican. Members of this family exhibit structural similarity: a G1 domain at the N-terminus and a G3 domain at the C-terminus, with a central sequence for modification by CS chains. A unique feature of aggrecan is the insertion of three additional domains, an inter-globular domain (IGD), a G2 domain and a keratan sulphate (KS) domain (sequence modified by KS chains), between the G1 domain and the CS domain (sequence modified by CS chains). The G1 and G3 domains have been implicated in product secretion, but G2, although structurally similar to the tandem repeats of G1, performs an unknown function. To define the functions of each aggrecan domain in product processing, we cloned and expressed these domains in various combinations in COS-7 cells. The results indicated that the G3 domain enhanced product secretion, alone or in combination with the KS or CS domain, and promoted glycosaminoglycan (GAG) chain attachment. Constructs containing the G1 domain were not secreted. Addition of a CS domain sequence to G1 reduced this inhibition, but GAG chain attachment was still decreased. The potential GAG chain attachment site in the IGD was occupied by GAGs, and IGD product was secreted efficiently. The KS domain was modified by GAG chains and secreted. Finally, the G2 domain was expressed but not secreted, and inhibited secretion of the IGD when expressed as an IGD-G2 combination.

Full Text

The Full Text of this article is available as a PDF (233.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binette F., Cravens J., Kahoussi B., Haudenschild D. R., Goetinck P. F. Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid. J Biol Chem. 1994 Jul 22;269(29):19116–19122. [PubMed] [Google Scholar]
  2. Cao L., Yang B. B. Chondrocyte apoptosis induced by aggrecan G1 domain as a result of decreased cell adhesion. Exp Cell Res. 1999 Feb 1;246(2):527–537. doi: 10.1006/excr.1998.4335. [DOI] [PubMed] [Google Scholar]
  3. Cao L., Zhang Y., Yang B. B. Expression of the G1 domain of aggrecan interferes with chondrocyte attachment and adhesion. Matrix Biol. 1998 Oct;17(5):379–392. doi: 10.1016/s0945-053x(98)90090-7. [DOI] [PubMed] [Google Scholar]
  4. Chandrasekaran L., Tanzer M. L. Molecular cloning of chicken aggrecan. Structural analyses. Biochem J. 1992 Dec 15;288(Pt 3):903–910. doi: 10.1042/bj2880903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Day J. M., Murdoch A. D., Hardingham T. E. The folded protein modules of the C-terminal G3 domain of aggrecan can each facilitate the translocation and secretion of the extended chondroitin sulfate attachment sequence. J Biol Chem. 1999 Dec 31;274(53):38107–38111. doi: 10.1074/jbc.274.53.38107. [DOI] [PubMed] [Google Scholar]
  6. Deák F., Kiss I., Sparks K. J., Argraves W. S., Hampikian G., Goetinck P. F. Complete amino acid sequence of chicken cartilage link protein deduced from cDNA clones. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3766–3770. doi: 10.1073/pnas.83.11.3766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Domowicz M. S., Pirok E. W., 3rd, Novak T. E., Schwartz N. B. Role of the C-terminal G3 domain in sorting and secretion of aggrecan core protein and ubiquitin-mediated degradation of accumulated mutant precursors. J Biol Chem. 2000 Nov 10;275(45):35098–35105. doi: 10.1074/jbc.275.45.35098. [DOI] [PubMed] [Google Scholar]
  8. Goetinck P. F. Proteoglycans in development. Curr Top Dev Biol. 1991;25:111–131. doi: 10.1016/s0070-2153(08)60413-5. [DOI] [PubMed] [Google Scholar]
  9. Kerr R. S., Newgreen D. F. Isolation and characterization of chondroitin sulfate proteoglycans from embryonic quail that influence neural crest cell behavior. Dev Biol. 1997 Dec 1;192(1):108–124. doi: 10.1006/dbio.1997.8731. [DOI] [PubMed] [Google Scholar]
  10. Li H., Schwartz N. B., Vertel B. M. cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. J Biol Chem. 1993 Nov 5;268(31):23504–23511. [PubMed] [Google Scholar]
  11. Lohmander L. S., Dahlberg L., Ryd L., Heinegård D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum. 1989 Nov;32(11):1434–1442. doi: 10.1002/anr.1780321113. [DOI] [PubMed] [Google Scholar]
  12. Lohmander L. S., Hoerrner L. A., Dahlberg L., Roos H., Björnsson S., Lark M. W. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. J Rheumatol. 1993 Aug;20(8):1362–1368. [PubMed] [Google Scholar]
  13. Luo W., Kuwada T. S., Chandrasekaran L., Zheng J., Tanzer M. L. Divergent secretory behavior of the opposite ends of aggrecan. J Biol Chem. 1996 Jul 12;271(28):16447–16450. doi: 10.1074/jbc.271.28.16447. [DOI] [PubMed] [Google Scholar]
  14. Margolis R. U., Margolis R. K. Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol. 1994;245:105–126. doi: 10.1016/0076-6879(94)45008-0. [DOI] [PubMed] [Google Scholar]
  15. Mjaatvedt C. H., Yamamura H., Capehart A. A., Turner D., Markwald R. R. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol. 1998 Oct 1;202(1):56–66. doi: 10.1006/dbio.1998.9001. [DOI] [PubMed] [Google Scholar]
  16. Primorac D., Stover M. L., Clark S. H., Rowe D. W. Molecular basis of nanomelia, a heritable chondrodystrophy of chicken. Matrix Biol. 1994 Aug;14(4):297–305. doi: 10.1016/0945-053x(94)90195-3. [DOI] [PubMed] [Google Scholar]
  17. Sai S., Tanaka T., Kosher R. A., Tanzer M. L. Cloning and sequence analysis of a partial cDNA for chicken cartilage proteoglycan core protein. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5081–5085. doi: 10.1073/pnas.83.14.5081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stirpe N. S., Argraves W. S., Goetinck P. F. Chondrocytes from the cartilage proteoglycan-deficient mutant, nanomelia, synthesize greatly reduced levels of the proteoglycan core protein transcript. Dev Biol. 1987 Nov;124(1):77–81. doi: 10.1016/0012-1606(87)90461-1. [DOI] [PubMed] [Google Scholar]
  19. Toole B. P. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol. 1990 Oct;2(5):839–844. doi: 10.1016/0955-0674(90)90081-o. [DOI] [PubMed] [Google Scholar]
  20. Vertel B. M., Grier B. L., Li H., Schwartz N. B. The chondrodystrophy, nanomelia: biosynthesis and processing of the defective aggrecan precursor. Biochem J. 1994 Jul 1;301(Pt 1):211–216. doi: 10.1042/bj3010211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vertel B. M., Walters L. M., Grier B., Maine N., Goetinck P. F. Nanomelic chondrocytes synthesize, but fail to translocate, a truncated aggrecan precursor. J Cell Sci. 1993 Mar;104(Pt 3):939–948. doi: 10.1242/jcs.104.3.939. [DOI] [PubMed] [Google Scholar]
  22. Vilim V., Fosang A. J. Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage: characterization of naturally occurring hyaluronan-binding fragments of aggrecan. Biochem J. 1994 Dec 15;304(Pt 3):887–894. doi: 10.1042/bj3040887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wai A. W., Ng L. J., Watanabe H., Yamada Y., Tam P. P., Cheah K. S. Disrupted expression of matrix genes in the growth plate of the mouse cartilage matrix deficiency (cmd) mutant. Dev Genet. 1998;22(4):349–358. doi: 10.1002/(SICI)1520-6408(1998)22:4<349::AID-DVG5>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  24. Watanabe H., Cheung S. C., Itano N., Kimata K., Yamada Y. Identification of hyaluronan-binding domains of aggrecan. J Biol Chem. 1997 Oct 31;272(44):28057–28065. doi: 10.1074/jbc.272.44.28057. [DOI] [PubMed] [Google Scholar]
  25. Watanabe H., Gao L., Sugiyama S., Doege K., Kimata K., Yamada Y. Mouse aggrecan, a large cartilage proteoglycan: protein sequence, gene structure and promoter sequence. Biochem J. 1995 Jun 1;308(Pt 2):433–440. doi: 10.1042/bj3080433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Watanabe H., Kimata K., Line S., Strong D., Gao L. Y., Kozak C. A., Yamada Y. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat Genet. 1994 Jun;7(2):154–157. doi: 10.1038/ng0694-154. [DOI] [PubMed] [Google Scholar]
  27. Yang B. B., Zhang Y., Cao L., Yang B. L. Aggrecan and link protein affect cell adhesion to culture plates and to type II collagen. Matrix Biol. 1998 Mar;16(9):541–561. doi: 10.1016/s0945-053x(98)90066-x. [DOI] [PubMed] [Google Scholar]
  28. Zhang Y., Cao L., Kiani C. G., Yang B. L., Yang B. B. The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. J Biol Chem. 1998 Dec 4;273(49):33054–33063. doi: 10.1074/jbc.273.49.33054. [DOI] [PubMed] [Google Scholar]
  29. Zhang Y., Cao L., Yang B. L., Yang B. B. The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs. J Biol Chem. 1998 Aug 14;273(33):21342–21351. doi: 10.1074/jbc.273.33.21342. [DOI] [PubMed] [Google Scholar]
  30. Zheng J., Luo W., Tanzer M. L. Aggrecan synthesis and secretion. A paradigm for molecular and cellular coordination of multiglobular protein folding and intracellular trafficking. J Biol Chem. 1998 May 22;273(21):12999–13006. doi: 10.1074/jbc.273.21.12999. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES